Home » Two deaths and more than 100 hospital admissions in Japan due to anti-cholesterol drugs

Two deaths and more than 100 hospital admissions in Japan due to anti-cholesterol drugs

by admin

Theme image — © Shutterstock

A major Japanese pharmaceutical company has recalled a cholesterol-lowering drug after two people died and more than 100 people became ill from taking it. The Guardian reports this.

Kobayashi Pharmaceutical, a company specializing in over-the-counter drugs and dietary supplements, has launched a nationwide recall, and Japanese authorities have launched an investigation into thousands of the company’s products. This concerns three brands of ‘beni koji choleste help’, with red yeast produced by fermenting rice, which is said to help lower bad cholesterol.

However, the fermentation process of the rice could also produce the poison citrinin, which causes kidney damage. One user is said to have used the product for three years and died of kidney disease. “We are aware of one case where there is a potential link between a death and our product,” Kobayashi Pharmaceutical said.

The Japanese Ministry of Health is also aware of a second death. “In total, we suspect a link with two deaths and 106 cases of possible hospital admissions,” a spokesperson said.

See also  Range of online notarial procedures expanded

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy